Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Karthik Ranganna"'
Autor:
Sarah E. Benner, Yolanda Eby, Xianming Zhu, Reinaldo E. Fernandez, Eshan U. Patel, Jessica E. Ruff, Feben Habtehyimer, Haley A. Schmidt, Charles S. Kirby, Sarah Hussain, Darin Ostrander, Niraj M. Desai, Sander Florman, Meenakshi M. Rana, Rachel Friedman-Moraco, Marcus R. Pereira, Shikha Mehta, Peter Stock, Alexander Gilbert, Michele I. Morris, Valentina Stosor, Sapna A. Mehta, Catherine B. Small, Karthik Ranganna, Carlos A.Q. Santos, Saima Aslam, Jennifer Husson, Maricar Malinis, Nahel Elias, Emily A. Blumberg, Brianna L. Doby, Allan B. Massie, Melissa L. Smith, Jonah Odim, Thomas C. Quinn, Gregory M. Laird, Robert F. Siliciano, Dorry L. Segev, Andrew D. Redd, Christine M. Durand, Aaron A.R. Tobian
Publikováno v:
JCI Insight, Vol 7, Iss 21 (2022)
The HIV latent viral reservoir (LVR) remains a major challenge in the effort to find a cure for HIV. There is interest in lymphocyte-depleting agents, used in solid organ and bone marrow transplantation to reduce the LVR. This study evaluated the LVR
Externí odkaz:
https://doaj.org/article/09d1623efd834d26a727f8f8faacd04a
Autor:
Gregory Malat, Meera N. Harhay, Sindhura Talluri, Alden Doyle, Karthik Ranganna, Dong Heun Lee, Suzanne M. Boyle, Tiffany E. Bias
Publikováno v:
Experimental and Clinical Transplantation. 18:153-156
Objectives Infection is a common cause of morbidity and mortality after kidney transplant. Based on the well-documented successes of reducing infections with decolonization of patients in intensive care units, we began a universal immediate posttrans
Autor:
Allison Hanlon, Timothy Patton, Christina L. Chung, Selim M. Arcasoy, Jenny Hu, Gavin Hickey, Rade Tomic, David G. Brodland, Garrett R. Roll, Nicolae Leca, Daniel F. Dilling, Jorge M. Mallea, Sarah T. Arron, Don Hayes, Sarah A. Myers, Norah A. Terrault, Daniel Berg, Mark Wigger, Alice L. Gray, Sofya Tokman, Lauren D. Crow, David A. Baran, Faramarz H. Samie, Matthew C. Fox, Erika D. Lease, Marcy Neuburg, James C. Lee, Bryan T. Carroll, Anokhi Jambusaria-Pahlajani, Robert Samuel Hopkins, A. Emtiazjoo, Milan J. Anadkat, William Black, Rajiv I. Nijhawan, John A. Carucci, Karthik Ranganna, Melissa Bleicher, John R. Griffin, Seaver L. Soon, Amanda R. Twigg, Jonathan E. Holtz, Alan Menter, Rehana L. Ahmed, Christie P. Thomas, Ramsey R. Hachem, Travis W. Blalock, Elizabeth M. Billingsley, Justin J. Leitenberger, Amit D. Parulekar, Teresa Soriano, George Chaux, Conway C. Huang, Shang I Brian Jiang, Vishal A. Patel, Jennifer A. Stein, Mark Abdelmalek, Clark C. Otley, So Yeon Paek, Timothy W. Chang, Manisha J. Patel, Ashwin K. Ravichandran, Jonathan P. Singer, Siddhartha G. Kapnadak, Alden M. Doyle, Shahid M. Malik, Shelley A. Hall, Kristin Bibee, Mariah Brown, Simin Goral, Daniel C. Brennan, Pooja Singh, Edward S. Kraus, Nathalie C. Zeitouni, Carrie Ann Cusack, Maria Isabel Longo, Douglas J. Norman, Rachel Redenius, Stefan E. Lowenstein, Ronald A. Squires, Sandra J. Taler, Thomas Stasko, Nkanyezi H. Ferguson, Mary Ann Lim, Thuzar M. Shin, Melissa Pugliano-Mauro, Scott W. Fosko
Publikováno v:
Transplant International. 32:1268-1276
Skin cancer is the most common malignancy affecting solid organ transplant recipients (SOTR), and SOTR experience increased skin cancer-associated morbidity and mortality. There are no formal multidisciplinary guidelines for skin cancer screening aft
Autor:
Gregory Malat, Rahul M. Jindal, Suzanne M. Boyle, Meera N. Harhay, Gary Xiao, Mysore S. Anil Kumar, Dong Heun Lee, Alden Doyle, Stephen Guy, Karthik Ranganna
Publikováno v:
American Journal of Kidney Diseases. 73:112-118
Hahnemann University Hospital has performed 120 kidney transplantations in human immunodeficiency virus (HIV)-positive individuals during the last 16 years. Our patient population represents ∼10% of the entire US population of HIV-positive kidney r
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation SocietyREFERENCES. 23(3)
Anti-Pneumocystis pneumonia (PCP) prophylaxis is recommended for 3 to 6 months post-transplant, in HIV-negative kidney transplant recipients. For HIV-positive kidney transplant recipients, there is no definite duration of primary prophylaxis and is o
Autor:
Meera N. Harhay, Gregory Malat, Karthik Ranganna, Dong Heun Lee, Suzanne M. Boyle, Abbas Raza, Catylin Deering, Kallie Fehr
Publikováno v:
Transpl Infect Dis
Background HIV-positive kidney transplant (KT) recipients have similar outcomes to HIV-negative recipients. However, HIV-positive patients with advanced kidney disease might face additional barriers to initiating the KT evaluation process. We sought
Autor:
Muhammad Aslam, Howard J. Eisen, Karthik Ranganna, Waqas J. Siddiqui, Muhammad Harisullah Khan, Abu Bakar, Muhammad Hanif, Chikezie Alvarez, Syed Farhan Hasni, Ayesha Aslam, Sandeep Aggarwal
Publikováno v:
The American Journal of Cardiology. 122:468-476
Acute kidney injury (AKI) is commonly associated with aortic valve replacement. Surgical aortic valve replacement (SAVR) is a known risk factor for AKI but little is known about the short- and long-term effects of transcatheter aortic valve implantat
Autor:
Meera N. Harhay, Suzanne M. Boyle, Karthik Ranganna, Gregory Malat, Dorry L. Segev, Gary Xiao, Antonia M. Brown, Mara McAdams-DeMarco, Thalia Bajakian, David J. Reich, Stephen Guy, Lissa Levin Mizrahi
Publikováno v:
Am J Kidney Dis
RATIONALE & OBJECTIVE: There is debate on whether weight loss, a hallmark of frailty, signals higher risk for adverse outcomes among deceased donor kidney transplant (DDKT) recipients. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS:
Autor:
Suzanne M. Boyle, Meera N. Harhay, David J. Reich, Gary Xiao, Karthik Ranganna, Ryan M. McKenna, Stephen Guy, Lissa Levin Mizrahi, Michael O. Harhay, Gregory Malat
Publikováno v:
Clinical journal of the American Society of Nephrology : CJASN. 13(7)
BACKGROUND AND OBJECTIVES: Before 2014, low-income individuals in the United States with non–dialysis-dependent CKD had fewer options to attain health insurance, limiting their opportunities to be preemptively wait-listed for kidney transplantation
Publikováno v:
Transplant Infectious Disease. 18:625-627
Dolutegravir is a preferred antiretroviral drug for human immunodeficiency virus (HIV)-infected patients following solid organ transplantation. It has potent antiretroviral activity and does not interact with calcineurin inhibitors. We describe a cas